scispace - formally typeset
P

Patrick Bourgouin

Publications -  5
Citations -  418

Patrick Bourgouin is an academic researcher. The author has contributed to research in topics: Medicine & TARDBP. The author has an hindex of 2, co-authored 2 publications receiving 377 citations.

Papers
More filters
Journal ArticleDOI

Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo.

TL;DR: Together these approaches showed that TARDBP mutations cause motor neuron defects and toxicity, suggesting that both a toxic gain of function as well as a novel loss of function may be involved in the molecular mechanism by which mutant TDP-43 contributes to disease pathogenesis.
Journal ArticleDOI

No TARDBP Mutations in a French Canadian Population of Patients With Parkinson Disease

TL;DR: This review concludes that the prion protein gene codon 129 modulates clinical course of neurological Wilson disease and is associated with cognitive impairment in the elderly: the EVA study.
Journal ArticleDOI

Sybil: A Validated Deep Learning Model to Predict Future Lung Cancer Risk From a Single Low-Dose Chest Computed Tomography

TL;DR: Sybil as mentioned in this paper uses a deep learning model assessing the entire volumetric low-dose computed tomography (LDCT) data to predict individual risk without requiring additional demographic or clinical data.
Journal ArticleDOI

Utility of Noncancerous Chest CT Features for Predicting Overall Survival and Noncancer Death in Patients With Stage I Lung Cancer Treated With Stereotactic Body Radiotherapy.

TL;DR: In patients undergoing SBRT for stage I lung cancer, higher CAC score, higher PA-to-aorta ratio, and lower thoracic skeletal muscle index independently predicted worse OS, compared with clinical features alone.
Journal ArticleDOI

Case 9-2022: A 56-Year-Old Woman with Fever, Myalgias, Diarrhea, and Cough.

TL;DR: A 56-year-old woman was admitted in the spring of 2020 because of fever, myalgias, diarrhea, and a dry cough, and she had had contact with a person with SARS-CoV-2 infection six weeks earlier.